Overview
Siro Simizu practices practicing medicine in Yokohama, Japan.
Their clinical expertise encompasses Fibrosarcoma, Albinism, Fibromatosis, and Breast Cancer.
They are actively involved in clinical research, co-authoring 75 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Siro Simizu
Is Siro Simizu a top-rated expert for Fibrosarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Siro Simizu is classified as an Experienced expert for Fibrosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Siro Simizu participate in research or clinical trials?
Yes. Siro Simizu has published 75 articles and abstracts on conditions like Fibrosarcoma. You can view a list of Siro Simizu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adult Soft Tissue SarcomaSimizu isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AlbinismSimizu isExperienced. Learn about Albinism.
- Breast CancerSimizu isExperienced. Learn about Breast Cancer.
- FibromatosisSimizu isExperienced. Learn about Fibromatosis.
- FibrosarcomaSimizu isExperienced. Learn about Fibrosarcoma.